Funding for this research was provided by:
Ministry of Health and Welfare (MOHW112-TDU-B-221-124007)
National Science and Technology Council (111-2314-B-002 -039)
National Medical Research Council (NMRC/CSA-SI/0013/2017, NMRC/OFLCG/003/2018)
Article History
Received: 3 September 2023
Accepted: 10 February 2024
First Online: 17 February 2024
Declarations
:
: Not applicable.
: Not applicable.
: Dr. Chiun Hsu received research grants from Bristol-Myers Squibb (BMS)/ ONO, Roche, and Ipsen and received honorarium from the following pharmaceutical companies: AstraZeneca, Bayer, BMS/ONO, Eisai, MSD, Novartis, Roche, TTY Biopharm. Dr. Chew and Dr. Chuang declared that they had no competing interests to disclose.